Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. 2002

Theodore C Pierson, and Tara L Kieffer, and Christian T Ruff, and Christopher Buck, and Stephen J Gange, and Robert F Siliciano
Department of Medicine, Johns Hopkins University School of Medicine, Johns Hopkins University School of Public Health, Baltimore, Maryland 21205, USA.

The development of surrogate markers capable of detecting residual ongoing human immunodeficiency virus type 1 (HIV-1) replication in patients receiving highly active antiretroviral therapy is an important step in understanding viral dynamics and in developing new treatment strategies. In this study, we evaluated the utility of circular forms of the viral genome for the detection of recent infection of cells by HIV-1. We measured the fate of both one-long terminal repeat (1-LTR) and 2-LTR circles following in vitro infection of logarithmically growing CD4+ T cells under conditions in which cell death was not a significant contributing factor. Circular forms of the viral genome were found to be highly stable and to decrease in concentration only as a function of dilution resulting from cell division. We conclude that these DNA circles are not intrinsically unstable in all cell types and suggest that the utility of 2-LTR circle assays in measuring recent HIV-1 infection of susceptible cells in vivo needs to be reevaluated.

UI MeSH Term Description Entries
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D004270 DNA, Circular Any of the covalently closed DNA molecules found in bacteria, many viruses, mitochondria, plastids, and plasmids. Small, polydisperse circular DNA's have also been observed in a number of eukaryotic organisms and are suggested to have homology with chromosomal DNA and the capacity to be inserted into, and excised from, chromosomal DNA. It is a fragment of DNA formed by a process of looping out and deletion, containing a constant region of the mu heavy chain and the 3'-part of the mu switch region. Circular DNA is a normal product of rearrangement among gene segments encoding the variable regions of immunoglobulin light and heavy chains, as well as the T-cell receptor. (Riger et al., Glossary of Genetics, 5th ed & Segen, Dictionary of Modern Medicine, 1992) Circular DNA,Circular DNAs,DNAs, Circular
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016325 HIV Long Terminal Repeat Regulatory sequences important for viral replication that are located on each end of the HIV genome. The LTR includes the HIV ENHANCER, promoter, and other sequences. Specific regions in the LTR include the negative regulatory element (NRE), NF-kappa B binding sites , Sp1 binding sites, TATA BOX, and trans-acting responsive element (TAR). The binding of both cellular and viral proteins to these regions regulates HIV transcription. HIV Negative Regulatory Element,HIV Sp1-Binding Site,HIV Trans-Acting Responsive Region,Human Immunodeficiency Virus Long Terminal Repeat,Long Terminal Repeat, HIV,Negative Regulatory Element, HIV,Sp1-Binding Site, HIV,Trans-Acting Responsive Region, HIV,HIV-1 LTR,Human Immunodeficiency Virus LTR,LTR, Human Immunodeficiency Virus,TAR Element, HIV,Trans-Activation Responsive Element, HIV,Trans-Activation Responsive Region, HIV,HIV 1 LTR,HIV Sp1 Binding Site,HIV Sp1-Binding Sites,HIV TAR Element,HIV TAR Elements,HIV Trans Acting Responsive Region,LTR, HIV-1,Sp1 Binding Site, HIV,Sp1-Binding Sites, HIV,TAR Elements, HIV,Trans Acting Responsive Region, HIV,Trans Activation Responsive Element, HIV,Trans Activation Responsive Region, HIV

Related Publications

Theodore C Pierson, and Tara L Kieffer, and Christian T Ruff, and Christopher Buck, and Stephen J Gange, and Robert F Siliciano
October 2005, AIDS research and therapy,
Theodore C Pierson, and Tara L Kieffer, and Christian T Ruff, and Christopher Buck, and Stephen J Gange, and Robert F Siliciano
April 2005, Journal of virology,
Theodore C Pierson, and Tara L Kieffer, and Christian T Ruff, and Christopher Buck, and Stephen J Gange, and Robert F Siliciano
August 2009, Antimicrobial agents and chemotherapy,
Theodore C Pierson, and Tara L Kieffer, and Christian T Ruff, and Christopher Buck, and Stephen J Gange, and Robert F Siliciano
March 2000, AIDS research and human retroviruses,
Theodore C Pierson, and Tara L Kieffer, and Christian T Ruff, and Christopher Buck, and Stephen J Gange, and Robert F Siliciano
May 2004, Journal of virology,
Theodore C Pierson, and Tara L Kieffer, and Christian T Ruff, and Christopher Buck, and Stephen J Gange, and Robert F Siliciano
March 2008, Journal of virology,
Theodore C Pierson, and Tara L Kieffer, and Christian T Ruff, and Christopher Buck, and Stephen J Gange, and Robert F Siliciano
July 2004, Journal of virology,
Theodore C Pierson, and Tara L Kieffer, and Christian T Ruff, and Christopher Buck, and Stephen J Gange, and Robert F Siliciano
May 1993, Proceedings of the National Academy of Sciences of the United States of America,
Theodore C Pierson, and Tara L Kieffer, and Christian T Ruff, and Christopher Buck, and Stephen J Gange, and Robert F Siliciano
July 1993, Proceedings of the National Academy of Sciences of the United States of America,
Theodore C Pierson, and Tara L Kieffer, and Christian T Ruff, and Christopher Buck, and Stephen J Gange, and Robert F Siliciano
October 2007, Clinical microbiology reviews,
Copied contents to your clipboard!